Teva Historical Cash Flow
| TEVA Stock | USD 16.59 0.10 0.60% |
Analysis of Teva Pharma cash flow over time is an excellent tool to project Teva Pharma Industries future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 767.4 M or Other Non Cash Items of 1.6 B as it is a great indicator of Teva Pharma ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Teva Pharma Industries latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Teva Pharma Industries is a good buy for the upcoming year.
Teva |
About Teva Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Teva balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Teva's non-liquid assets can be easily converted into cash.
Teva Pharma Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Teva Pharma's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Teva Pharma Industries current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At present, Teva Pharma's Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 133.2 M, whereas Change To Inventory is projected to grow to (139.7 M).
| 2021 | 2023 | 2024 (projected) | Other Non Cash Items | 714M | 1.1B | 1.6B | Depreciation | 1.3B | 1.2B | 767.4M |
Teva Pharma cash flow statement Correlations
Click cells to compare fundamentals
Teva Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Teva Pharma cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 271M | 41M | 380M | (163M) | (147M) | (139.7M) | |
| Change In Cash | 734M | 202M | 21M | 636M | 393M | 412.7M | |
| Stock Based Compensation | 155M | 20M | 129M | 119M | 121M | 133.2M | |
| Free Cash Flow | 419M | 638M | 236M | 1.0B | 842M | 1.5B | |
| Change In Working Capital | (112M) | (2.2B) | (1.7B) | 1.3B | (72M) | (75.6M) | |
| Begin Period Cash Flow | 1.2B | 2.0B | 2.2B | 2.2B | 2.8B | 3.0B | |
| Other Cashflows From Financing Activities | 2.0B | (5M) | (6M) | (118M) | (212M) | (201.4M) | |
| Depreciation | 1.8B | 416M | 1.6B | 1.3B | 1.2B | 767.4M | |
| Other Non Cash Items | 471M | 6.5B | 714M | 2.4B | 1.1B | 1.6B | |
| Capital Expenditures | 119M | 578M | 562M | 548M | 526M | 486.4M | |
| Total Cash From Operating Activities | 538M | 1.2B | 798M | 1.6B | 1.4B | 2.0B | |
| Net Income | 76M | (4.1B) | 456M | (2.4B) | (615M) | (584.3M) | |
| Total Cash From Financing Activities | (241M) | (1.9B) | (2.2B) | (1.5B) | (1.9B) | (1.8B) | |
| End Period Cash Flow | 2.0B | 2.2B | 2.2B | 2.8B | 3.2B | 3.4B | |
| Change To Liabilities | 643M | (463M) | 764M | 1.9B | 2.2B | 2.3B | |
| Change To Account Receivables | (394M) | (293M) | (574M) | 334M | 12M | 11.4M | |
| Other Cashflows From Investing Activities | 1.6B | 1.5B | 1.4B | 1.9B | 2.2B | 2.3B | |
| Total Cashflows From Investing Activities | 1.4B | 863M | 1.5B | 656M | 754.4M | 792.1M | |
| Change To Operating Activities | (1.4B) | (2.2B) | (1.7B) | (828M) | (745.2M) | (782.5M) | |
| Investments | 343M | 67M | 172M | 656M | 968M | 1.0B | |
| Net Borrowings | (1.9B) | (1.9B) | (1.7B) | (1.4B) | (1.2B) | (1.2B) | |
| Change To Netincome | 1.9B | 6.9B | 729M | 1.4B | 1.2B | 1.2B | |
| Cash And Cash Equivalents Changes | 961M | 177M | 194M | 149M | 134.1M | 233.0M | |
| Cash Flows Other Operating | (2.7B) | (1.9B) | (4.6B) | (4.0B) | (3.6B) | (3.8B) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.4 | Earnings Share (0.85) | Revenue Per Share 14.879 | Quarterly Revenue Growth 0.125 | Return On Assets 0.0556 |
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.